#BostonUni

The Parkinson’s disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration Nature Microbiology - Entacapone, a Parkinson’s disease medication, sequesters iron resulting in a selective inhibition of gut microbial activity.

Our study on drug-gut microbiome interactions is out!
🦠💊

We show that the #Parkinson's drug entacapone induces iron deficiency in microbes, leading to selective inhibition of microbial activity.

@cemess.bsky.social @sotonbiosciences.bsky.social #BostonUni

Check the full story here: rdcu.be/d0ZAQ